Eton Park Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Eton Park Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-607,983	Closed	-$105M	–	47
2015 Q1	$105M	Buy	+607,983	New	+$89.3M	3.04%	16

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Eton Park Capital Management's SLXP Position: Q2 2015 in Review

Eton Park Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 607,983 shares — an estimated $105M sold.

Eton Park Capital Management first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $105M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Eton Park Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Eton Park Capital Management sold 607,983 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $105M.
Eton Park Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
Eton Park Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $105M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Eton Park Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.